Capital International Sarl’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.87M	Buy	102,278 +7,509	+8%	+$396K	0.08%	150
2025 Q4	$4.97M	Sell	94,769 -4,888	-5%	-$293K	0.08%	153
2025 Q3	$6.46M	Buy	99,657 +8,140	+9%	+$467K	0.11%	132
2025 Q2	$4.45M	Sell	91,517 -11,425	-11%	-$442K	0.09%	152
2025 Q1	$3.5M	Sell	102,942 -83,978	-45%	-$3.56M	0.08%	160
2024 Q4	$7.36M	Buy	186,920 +16,397	+10%	+$774K	0.17%	117
2024 Q3	$8.01M	Buy	170,523 +21,130	+14%	+$1.07M	0.21%	106
2024 Q2	$8.07M	Buy	149,393 +7,485	+5%	+$433K	0.25%	97
2024 Q1	$9.67M	Buy	141,908 +39,234	+38%	+$2.81M	0.32%	87
2023 Q4	$6.43M	Buy	102,674 +10,531	+11%	+$582K	0.24%	102
2023 Q3	$4.18M	Buy	92,143 +6,708	+8%	+$346K	0.19%	125
2023 Q2	$4.8M	Buy	85,435 +8,063	+10%	+$458K	0.22%	124
2023 Q1	$3.5M	Buy	77,372 +18,855	+32%	+$916K	0.18%	139
2022 Q4	$2.38M	Buy	58,517 +8,620	+17%	+$457K	0.17%	145
2022 Q3	$3.26M	Buy	49,897 +18,618	+60%	+$1.35M	0.26%	109
2022 Q2	$1.9M	Buy	31,279 +7,090	+29%	+$417K	0.15%	150
2022 Q1	$1.52M	Buy	24,189 +4,027	+20%	+$253K	0.08%	207
2021 Q4	$1.53M	Buy	20,162 +16,234	+413%	+$1.42M	0.07%	204
2021 Q3	$440K	Sell	3,928 -274	-7%	-$34.4K	0.04%	211
2021 Q2	$680K	Sell	4,202 -1,766	-30%	-$215K	0.06%	192
2021 Q1	$727K	Sell	5,968 -4,175	-41%	-$630K	0.07%	187
2020 Q4	$1.55M	Buy	10,143 +658	+7%	+$77.8K	0.16%	127
2020 Q3	$793K	Buy	+9,485	New	+$841K	0.1%	155